Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial

Kim CY, et al.: J Neurooncol. 2020 Feb;146（3）:399-406. doi: 10.1007/s11060-019-03361-2.